Merck & Co., Inc.
MRK
$115.61
-$0.30-0.26%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.40B | 17.28B | 15.81B | 15.53B | 15.62B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.40B | 17.28B | 15.81B | 15.53B | 15.62B |
| Cost of Revenue | 4.30B | 3.75B | 3.39B | 3.38B | 3.71B |
| Gross Profit | 12.11B | 13.53B | 12.41B | 12.15B | 11.92B |
| SG&A Expenses | 2.73B | 2.48B | 2.50B | 2.40B | 2.69B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.03B | 10.23B | 9.88B | 9.31B | 7.53B |
| Operating Income | 5.38B | 7.05B | 5.92B | 6.22B | 8.10B |
| Income Before Tax | 3.42B | 6.75B | 5.00B | 5.90B | 4.17B |
| Income Tax Expenses | 458.00M | 958.00M | 571.00M | 818.00M | 426.00M |
| Earnings from Continuing Operations | 2.96B | 5.79B | 4.43B | 5.09B | 3.74B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | -2.00M | -1.00M | -6.00M | -1.00M |
| Net Income | 2.96B | 5.79B | 4.43B | 5.08B | 3.74B |
| EBIT | 5.38B | 7.05B | 5.92B | 6.22B | 8.10B |
| EBITDA | 6.79B | 8.15B | 6.99B | 7.28B | 9.21B |
| EPS Basic | 1.19 | 2.32 | 1.76 | 2.01 | 1.48 |
| Normalized Basic EPS | 1.25 | 1.69 | 1.41 | 1.49 | 1.92 |
| EPS Diluted | 1.19 | 2.32 | 1.76 | 2.01 | 1.48 |
| Normalized Diluted EPS | 1.25 | 1.69 | 1.41 | 1.48 | 1.92 |
| Average Basic Shares Outstanding | 2.49B | 2.50B | 2.51B | 2.52B | 2.54B |
| Average Diluted Shares Outstanding | 2.49B | 2.50B | 2.51B | 2.53B | 2.54B |
| Dividend Per Share | 0.81 | 0.81 | 0.81 | 0.81 | 0.77 |
| Payout Ratio | 68.11% | 35.11% | 46.92% | 40.36% | 52.12% |